-
September 11, 2012
Mylan Inc. (MYL) recently announced that it has entered into a settlement agreement with Pfizer Inc. (PFE), ...
-
September 07, 2012
Recently, Celgene Corporation (CELG) announced encouraging data from two phase III studies (PALACE-2, PALACE-3), ...
-
September 06, 2012
We are maintaining our Neutral recommendation on Bristol-Myers Squibb Company (BMY) with a target price of $35.00. ...
-
September 06, 2012
Pfizer Inc. (PFE) received approval for another oncology candidate recently. Bosulif (bosutinib) gained US Food and ...
-
September 05, 2012
Pfizer Inc. (PFE) recently announced European Commission (EC) approval of its renal cell cancer drug, Inlyta ...
-
September 05, 2012
The HealthCare unit of Bayer (BAYRY) recently submitted a new drug application (NDA) with the US Food and Drug ...
-
August 30, 2012
AstraZeneca (AZN) recently announced that the European Commission (EC) has approved Zinforo (ceftaroline fosamil) ...
-
August 29, 2012
AstraZeneca (AZN) recently announced that Pascal Soriot has been recruited as the new Chief Executive Officer (CEO) ...
-
August 28, 2012
Eli Lilly and Company (LLY) recently announced much awaited top-line results on Alzheimer's disease candidate, ...
-
August 28, 2012
Sanofi's (SNY) subsidiary, Genzyme, recently announced that the US Food and Drug Administration (FDA) has issued a ...
-
August 27, 2012
Bristol-Myers Squibb Company (BMY) recently suffered a pipeline setback when it announced the discontinuation of the ...
-
August 27, 2012
GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) recently announced that they have completed the phase III program ...
-
August 23, 2012
Mylan (MYL) has joined forces with Pfizer (PFE) to develop, manufacture, distribute and commercialize generic drugs ...
-
August 22, 2012
The US Food and Drug Administration (FDA) recently extended its review period for Pfizer's (PFE) rheumatoid ...
-
August 21, 2012
Watson Pharmaceuticals Inc. (WPI) recently announced the launch of an authorized generic version of Sunovion ...
-
August 17, 2012
Sanofi (SNY) recently gained US Food and Drug Administration approval for Auvi-Q (epinephrine injection) for the ...
-
August 17, 2012
Watson Pharmaceuticals Inc. (WPI) recently announced the filing of a lawsuit against the US Food and Drug ...
-
August 17, 2012
Pfizer Inc. (PFE) recently announced the filing of a registration statement by its subsidiary, Zoetis Inc. The ...
-
August 16, 2012
Pfizer (PFE) recently entered into an agreement with AstraZeneca (AZN) for the marketing of an over-the-counter ...
-
August 16, 2012
New York, August 16th (TradersHuddle.com) - Pfizer, Inc. (NYSE:PFE) closed the trading
day at $24.04, near its 50 ...
